Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With Ascites
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
To observe the safety/efficacy of tolvaptan for treatment of patients with hepatic cirrhosis
with ascites and exploring the dosage-effect relations of the drug.